说明:双击或选中下面任意单词,将显示该词的音标、读音、翻译等;选中中文或多个词,将显示翻译。
您的位置:首页 -> 句库 -> 农药企业
1.
Study on the Present Condition and the Countermeasure of Our Country Agrochemical Business Enterprise Logistics;
我国农药企业物流管理的现状及对策
2.
The Index System and Evaluation Method on Corporation Social Responsibility of Pesticide Enterprises;
农药企业社会责任指标体系与评价方法
3.
Game Analysis of the Combination of Pesticide Enterprises and the Efficiency of Using Resources;
整合农药企业与资源利用效率问题的博弈分析
4.
Vertical Distribution of Pollutants in Soils of a Former Organochlorine Pesticide Manufacturing Field
有机氯农药企业搬迁遗留场地土壤中污染物的垂向分布特征
5.
Study on the Guidance and Standard of Countryside Drug Supplying Enterprise in China;
引导和规范农村药品配送企业的探讨
6.
Research of strategies of pharmacy production enterprises exploiting rural area market;
药品生产企业开发农村市场的策略研究
7.
Features of Corporation Social Responsibility on the Multinational Pesticide Corporation and its Enlightenment in China;
跨国农药公司企业社会责任的特点及对中国的启示
8.
Research on enterprises of agricultureⅢ:Management of industrial agriculture enterprise and management of regional agriculture enterprise;
行业农业企业经营与区域农业企业经营——农业企业系列研究之三
9.
It omits agriculture and medicine.
它不包括农业和医药。
10.
nuclear agro industrial complex
核能农工业联合企业
11.
Pharmaceutical Enterprise and ISO14001;
药品生产企业与ISO14001认证
12.
Research on innovation of the agricultural enterprises Ⅱ. The agricul-tural enterprises is a substitution strategy of the agricultural;
农业企业化是农业产业化的替代战略——农业企业化创新研究之二
13.
Pharmaceutical trading enterprise" means an enterprise exclusively or partly engaged in the trade of pharmaceuticals.
药品经营企业,是指经营药品的专营企业或者兼营企业。
14.
China's pharmaceutical enterprises will accelerate the pace of new medicine development
中国制药企业将加快新药开发步伐
15.
Research of Chinese Pharmaceutical Enterprise Novel Drug Development Strategy;
我国制药企业创新药物研发战略研究
16.
Talking about GAP Plant of Chinese Medicine and Development of Medical Enterprise;
浅谈中药材GAP种植与医药企业的发展
17.
Discussion on Issues Concerning Chinese Pharmaceutical Enterprises Drug Patents;
我国制药企业药品专利相关问题初探
18.
Risks Avoidance in the Course of New Drugs R&D;
我国制药企业新药研发的风险与对策